首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Prolyl Isomerase Pin1 Promotes Amyloid Precursor Protein (APP) Turnover by Inhibiting Glycogen Synthase Kinase-3β (GSK3β) Activity
【2h】

Prolyl Isomerase Pin1 Promotes Amyloid Precursor Protein (APP) Turnover by Inhibiting Glycogen Synthase Kinase-3β (GSK3β) Activity

机译:脯氨酰异构酶Pin1通过抑制糖原合酶激酶3β(GSK3β)活性促进淀粉样前体蛋白(APP)的转换。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Alzheimer disease (AD) is characterized by the presence of senile plaques of amyloid-β (Aβ) peptides derived from amyloid precursor protein (APP) and neurofibrillary tangles made of hyperphosphorylated Tau. Increasing APP gene dosage or expression has been shown to cause familial early-onset AD. However, whether and how protein stability of APP is regulated is unclear. The prolyl isomerase Pin1 and glycogen synthase kinase-3β (GSK3β) have been shown to have the opposite effects on APP processing and Tau hyperphosphorylation, relevant to the pathogenesis of AD. However, nothing is known about their relationship. In this study, we found that Pin1 binds to the pT330-P motif in GSK3β to inhibit its kinase activity. Furthermore, Pin1 promotes protein turnover of APP by inhibiting GSK3β activity. A point mutation either at Thr-330, the Pin1-binding site in GSK3β, or at Thr-668, the GSK3β phosphorylation site in APP, abolished the regulation of GSK3β activity, Thr-668 phosphorylation, and APP stability by Pin1, resulting in reduced non-amyloidogenic APP processing and increased APP levels. These results uncover a novel role of Pin1 in inhibiting GSK3β kinase activity to reduce APP protein levels, providing a previously unrecognized mechanism by which Pin1 protects against Alzheimer disease.
机译:阿尔茨海默病(AD)的特征是存在淀粉样前体蛋白(APP)和由高磷酸化Tau制成的神经原纤维缠结衍生的淀粉样β-(Aβ)肽的老年斑。研究表明,增加APP基因的剂量或表达会导致家族性早发AD。然而,尚不清楚是否以及如何调节APP的蛋白质稳定性。脯氨酰异构酶Pin1和糖原合酶激酶3β(GSK3β)已显示对APP加工和Tau过度磷酸化具有相反的作用,与AD的发病机制有关。但是,他们之间的关系一无所知。在这项研究中,我们发现Pin1与G​​SK3β中的pT330-P基序结合以抑制其激酶活性。此外,Pin1通过抑制GSK3β活性来促进APP的蛋白质更新。 Thr 330(GSK3β中的Pin1结合位点)或点Thr(668)(APP中的GSK3β磷酸化位点)的点突变取消了Pin1对GSK3β活性,Thr-668磷酸化和APP稳定性的调节,导致减少了非淀粉样的APP加工并提高了APP水平。这些结果揭示了Pin1在抑制GSK3β激酶活性以降低APP蛋白水平方面的新作用,提供了Pin1预防阿尔茨海默氏病的先前未被认识的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号